MedPath

Interventions for mild to moderate permanent childhood hearing impairments identified by neonatal hearing screening

Completed
Conditions
Ear, nose and throat diseases
Ear, Nose and Throat
Hearing impairment
Registration Number
ISRCTN74171163
Lead Sponsor
Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
0
Inclusion Criteria

Children identified with permanent mild or moderate hearing impairment by neonatal screening.

Exclusion Criteria

Not provided at time of registration.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The societal costs (direct and indirect) associated with the different interventions will be estimated together with the associated benefits in terms of quality of life (including quality of family life and detailed behavioural and emotional aspects of development). The major outcomes assessed on 4 occasions (ages 9-12, 15-18, 21-24 months and final visit) will be (i) compliance with amplification, (ii) expressive and receptive speech and language (iii) QoL for child and family and (iv) behavioural and emotional measures. Costs will be estimated in a similar way to those in our present studies assessing outcomes in UK children who have had a cochlear implant or a hearing aid.
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration.
© Copyright 2025. All Rights Reserved by MedPath